Page last updated: 2024-10-18

dihydroxyphenylalanine and Bilateral Wilms Tumor

dihydroxyphenylalanine has been researched along with Bilateral Wilms Tumor in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LaBrosse, EH1
Comoy, E1
Bohuon, C1
Zucker, JM1
Schweisguth, O1
Kharchenko, AD1
Kniazev, IuA1
Bukhny, AE1
Kovalev, GP1
Kosiakov, GA1

Other Studies

2 other studies available for dihydroxyphenylalanine and Bilateral Wilms Tumor

ArticleYear
Catecholamine metabolism in neuroblastoma.
    Journal of the National Cancer Institute, 1976, Volume: 57, Issue:3

    Topics: Catecholamines; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Metho

1976
[Diurnal urine excretion of catecholamines and DOPA in tumors of the sympathetic nervous system in children].
    Pediatriia, 1969, Volume: 48, Issue:5

    Topics: Adolescent; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Lymphom

1969